Furthermore, aucubin inhibited the phosphorylation and expression of the BCR-ABL protein in human myeloid leukemia cells, where BCR-ABL encoded tyrosine kinases—i.e., an enzyme playing an essential role in many cell functions, e.g., signaling and cell growth [90]. Here, BCR is linked to myeloid leukemia.